Riverstone Holdings *Official* (SGX: AP4)

wahkao3

High Supremacy Member
Joined
Mar 6, 2005
Messages
26,805
Reaction score
23
TA goot
FA goot
both say buy, can buy :o
peaceful-river-pebble-rocks-water.jpg
 

Prime 13

High Supremacy Member
Joined
Feb 22, 2014
Messages
27,304
Reaction score
11,182
Fundamentals quite good.
Yield quite good too.
Most recent support at ~91c.

Price just established and retreated from 52 week high.
RSI also just came down from overbought.
P/B and P/E are also sky-high.

In short, good stock, but way too expensive now.
 

Keverus

Banned
Joined
Aug 30, 2008
Messages
80,617
Reaction score
0
who started this thread :mad:

this counter was in my review list last yr...but i passed up on this for tuan sing and centurion instead. sian.

but at this price...i think too high already. tread carefully.
 

royalshadow

Junior Member
Joined
Nov 2, 2015
Messages
11
Reaction score
0
Anyone vested in this counter? Why are ppl so bearish? I thought their last quarterly result is quite impressive? And yet it gets sell down a lot recently..
 

motome

Junior Member
Joined
Apr 24, 2005
Messages
64
Reaction score
0
riverstone down almost 10% after recent quarter earnings. anyone buying in? p/e below 16 liao.
 

Shion

Senior Mentor
Joined
Oct 24, 2008
Messages
359,173
Reaction score
109,398
Riverstone’s 3Q earnings drop 16% to $7 mil

Riverstone’s 3Q earnings drop 16% to $7 mil

http://www.theedgemarkets.com.sg/sg/article/riverstone’s-3q-earnings-drop-16-7-mil

SINGAPORE (Nov 9): Riverstone Holdings has reported earnings of RM20.8 million ($6.8 million) for 3QFY16, a 15.6% decrease from the earnings of RM35.3 million in 3QFY15.

For the quarter to September, revenue rose 10.9% to RM167million.

However, gross profit margins fell by 5.8 percentage points to 26.1% from the decrease in average selling prices of healthcare gloves.

Selling and distribution expenses fell 2.4% to RM4 million from lower marketing expenses and general and administrative expenses fell 33.3% to RM5.4 million on lower commission and incentives.

Other operating expenses was RM0.5 million, compared with other operating income of RM3.8 million in 3QFY15, driven by lower net foreign exchange gain and higher research and development expenses.

Riverstone said a number of challenges remain for the group, from the movement in commodity prices, the US currency fluctuation and competition from other glove manufacturers.

Meanwhile, the group’s third phase of its expansion plan in Perak remains on track, and Riverstone expects to have a total annual production capacity of 6.2 billion gloves by year-end.

The group has also started on its four phase of expansion which involves the construction of a new factory building to house dipping production lines, and could potentially add another 1 billion in glove production capacity by end 2017.

Shares in Riverstone closed 3 cents lower at 89 cents on Wednesday.
 

Shion

Senior Mentor
Joined
Oct 24, 2008
Messages
359,173
Reaction score
109,398
Riverstone’s gloves remains a hot investment to wear and invest in, say analysts

Riverstone’s gloves remains a hot investment to wear and invest in, say analysts

https://www.theedgesingapore.com/ca...s-hot-investment-wear-and-invest-say-analysts

SINGAPORE (May 13): Earnings of Malaysia-based glove and face mask manufacturer Riverstone Holdings soared 54.3% to RM46.6 million ($15.2 million) in 1Q20, from RM30.2 million a year ago, reinforcing that protective health gear are now the hottest investment property.
Revenue for 1Q20 correspondingly increased 16.2% to RM297.4 million from the RM30.2 million recorded in 1Q19, following robust global demand for healthcare products amid the Covid-19 pandemic.

A further boost in earnings came from a downtrend from the prices of Butadiene, a raw material used to produce Riverstone’s nitrile-based gloves.

As such, the group’s gross profit margin strengthened by 4.6 percentage points year-on-year to 24.0% in the quarter.

Riverstone is now ramping up its production levels to match the uptick in orders for health-protective gear from both its new and existing customers. For one, it is looking to increase its production capacity by 1.4 billion or 15.6% to 10.4 billion pieces of gloves per annum by 4Q20.

This will be done at its new facility, which constitutes phase 6 of Riverstone’s expansion plans, the group states in a regulatory filing on May 11.

“Completion of our new facility for phase 6 of our capacity expansion plans has come at an opportune time, and we are progressively commissioning new lines to satisfy our customers’ urgent need for examination gloves,” notes Executive Chairman and CEO, Wong Teek Son.

“Due to the surge in healthcare glove orders resulting from the Covid-19 pandemic, we have been ramping up production and reducing downtime for our production lines to meet this robust demand”.

As at end March, cash and cash equivalents stood at RM 170.7 million, down from RM 130.3 million a year ago, giving the group sufficient funding capacity to execute its expansion plans.

Looking at the group’s results, CGS-CIMB Ong Khang Chuen says it is 30% higher than forecasts by his team and Bloomberg. “The key surprise was stronger-than-expected margin expansion which widened mainly due to 1) favourable supply-demand dynamics leading to a better pricing environment and 2) lower raw material prices,” he says in a May 12 note.

Amid a heightened emphasis on hygiene, Ong anticipates Riverstone to see a spike in demand for gloves among both healthcare and non-healthcare sectors.

Already he notes that the company has an order backlog of around three to four months for cleanroom gloves, as opposed to an average of one month prior to the pandemic. This translates to its present operation level of 95%, as opposed to 88% previously.

To this end, he expects the group to record sales growth of 17% in FY20F bringing earnings up 61% to RM 210 million for the year. DBS analyst Ling Lee Keng has forecast a higher earnings growth of 27%/19% for FY20F/FY21F given the group’s ability to “generate above-industry margins”, particularly for cleanroom gloves.

Both Ong and Ling have posted “buy” or “add” calls on Riverstone at a target price of $1.86 and $2.20 respectively. This is a significant deviation from the $1.47 the group is currently trading at.

To Ling, Riverstone’s current price-to-earnings of 17.7x and 18.3x on FY20F and FY21F sees it trading at a 42% discount compared to its peers.

“This is unjustifiable, in our view, given its leadership position in the cleanroom segment. We see value in Riverstone’s hard-to-replicate cleanroom business that sets it apart from its competitors,” she stresses in a May 12 note.

As at 1.11pm shares at Riverstone Holdings were up 22 cents of 13.6% to $1.84.
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ. Forum members and moderators are responsible for their own posts.

Please refer to our Community Guidelines and Standards, Terms of Service and Member T&Cs for more information.
Top